Genomic sequencing and characterization of cynomolgus macaque cytomegalovirus

Angie K Marsh1, David O Willer, Aruna P N Ambagala

  • 1Department of Microbiology, Mount Sinai Hospital, Room 1484, 600 University Avenue, Toronto, ON, Canada.

Journal of Virology
|October 14, 2011
PubMed

Insights

A new cynomolgus macaque cytomegalovirus (CyCMV) genome sequence provides a valuable animal model for studying human cytomegalovirus (CMV) infection and developing CMV vaccines.

Area of Science:

  • Virology
  • Genomics
  • Immunology

Background:

  • Cytomegalovirus (CMV) is a major opportunistic infection in immunocompromised individuals and a leading cause of infant developmental disabilities.
  • Species-specific CMV necessitates relevant animal models for human CMV (HCMV) research and vaccine development.

Purpose of the Study:

  • To present the genomic sequence of a novel nonhuman primate cytomegalovirus (CyCMV) from cynomolgus macaques.
  • To evaluate CyCMV as a potential model for studying HCMV biology and vaccine development.

Main Methods:

  • Isolation of CyCMV (Ottawa strain) from a healthy cynomolgus macaque.
  • Next-generation Illumina sequencing of the viral genome.
  • Bioinformatic analysis to identify open reading frames (ORFs) and compare genomic organization with other CMV strains.

Main Results:

  • The complete CyCMV genome sequence (218,041 bp) was determined with 262 putative ORFs.
  • Genomic organization is largely colinear with rhesus macaque CMV (RhCMV).
  • CyCMV shares homology with HCMV genes, including four ORFs absent in RhCMV, and lacks a cyclooxygenase-2 homologue, similar to HCMV.

Conclusions:

  • The characterized CyCMV genome provides a new resource for CMV research.
  • CyCMV represents a promising animal model for investigating HCMV pathogenesis and advancing vaccine development efforts.